Literature DB >> 7286893

HLA typing in idiopathic hemochromatosis: distinction between homozygotes and heterozygotes with biochemical expression.

M L Bassett, J W Halliday, L W Powell.   

Abstract

In a study of 20 families with idiopathic hemochromatosis, relatives of probands were classified as either homozygous, heterozygous, or normal according to their HLA phenotype. An abnormality in the serum iron concentration, total iron-binding capacity, or serum ferritin concentration was present in all homozygotes and in 25% of heterozygotes. In heterozygotes, the mean total iron-binding capacity was significantly decreased, and the mean hepatic iron concentration was significantly increased compared to normals. However, in contrast to homozygotes, clinical evidence of iron overload was not observed in heterozygotes, and there was no biochemical or histological evidence of liver disease resulting from excessive iron stores. Progressive iron overload did not develop in 44 heterozygotes who were studied for up to 16 yr.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7286893     DOI: 10.1002/hep.1840010206

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  12 in total

1.  The HLA linked iron loading gene in an Afrikaner population.

Authors:  T E Meyer; D Ballot; T H Bothwell; A Green; D P Derman; R D Baynes; T Jenkins; P L Jooste; E D du Toit; P J Jacobs
Journal:  J Med Genet       Date:  1987-06       Impact factor: 6.318

2.  DNA polymorphism related to the idiopathic hemochromatosis gene: evidence in a recombinant family.

Authors:  V David; P Paul; M Simon; J Y Le Gall; R Fauchet; I Gicquel; I Dugast; L Le Mignon; J Yaouanq; D Cohen
Journal:  Hum Genet       Date:  1986-10       Impact factor: 4.132

3.  Combined segregation and linkage analysis of genetic hemochromatosis using affection status, serum iron, and HLA.

Authors:  I B Borecki; G M Lathrop; G E Bonney; J Yaouanq; D C Rao
Journal:  Am J Hum Genet       Date:  1990-09       Impact factor: 11.025

Review 4.  Current concepts in rational therapy for haemochromatosis.

Authors:  D H Crawford; J W Halliday
Journal:  Drugs       Date:  1991-06       Impact factor: 9.546

5.  The significance of haemochromatosis gene mutations in the general population: implications for screening.

Authors:  M J Burt; P M George; J D Upton; J A Collett; C M Frampton; T M Chapman; T A Walmsley; B A Chapman
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

6.  Hepatic iron in hemochromatosis.

Authors:  P C Adams
Journal:  Dig Dis Sci       Date:  1990-06       Impact factor: 3.199

7.  Hemochromatosis gene mutations: prevalence and effects on pegylated-interferon and ribavirin therapy response in chronic hepatitis C in sardinia.

Authors:  Margherita Sini; Orazio Sorbello; Alberto Civolani; Luigi Demelia
Journal:  J Clin Exp Hepatol       Date:  2012-09-21

8.  Intrafamilial variation in hereditary hemochromatosis.

Authors:  P C Adams
Journal:  Dig Dis Sci       Date:  1992-03       Impact factor: 3.199

9.  Idiopathic hemochromatosis: demonstration of homozygous-heterozygous mating by HLA typing of families.

Authors:  M L Bassett; T J Doran; J W Halliday; H V Bashir; L W Powell
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

10.  Segregation of genetic hemochromatosis indexed by latent capacity of transferrin.

Authors:  I B Borecki; D C Rao; J Yaouanq; J M Lalouel
Journal:  Am J Hum Genet       Date:  1989-09       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.